Drug Type Small molecule drug |
Synonyms EHT 1610, EHT1610 |
Target |
Mechanism DYRK1A inhibitors(Dual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14FN5O2S |
InChIKeyRYBNARZBIXTFJS-UHFFFAOYSA-N |
CAS Registry1425945-60-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Genetic Diseases, Inborn | Discovery | FR | 01 Oct 2014 | |
Neoplasms | Discovery | FR | 01 Oct 2014 | |
Neurodegenerative Diseases | Discovery | FR | 01 Oct 2014 |